|
[1]
|
高振东.新型纳米结构脂质载体给药系统的研究进展[J].中国药业,2013,22(4):93-94. |
|
[2]
|
温 许,胡雄伟,吴 昊,等.纳米结构脂质载体用于难溶性药物口服传递研究进展[J].药学实践杂志,2012,30(4):254-257. |
|
[3]
|
Mozafari MR. Nanoliposomes:preparation andanalysis[J].Methods Mol Biol,2010,605:29. |
|
[4]
|
曹丰亮,郭晨煜,李其禄,等.纳米结构脂质载体的制备与应用研究进展[J].中国生化药物杂志,2012,33(1):93-96. |
|
[5]
|
Cone RA.Barrier properties of mucus[J].Adv Drug Deliv Rev,2009,61:75-85. |
|
[6]
|
Müller RH,Radtke M,Wissing SA.Nanostructured lipid matrices for improved microencapsuhtion of drugs[J].Int J Pharm,2002,242(1-2):121-128. |
|
[7]
|
Sigfridssonk K, Lundquvist AJ, Strimfors M. Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development[J].Drug Dev Ind Pharm,2009,35(12):1479-1486. |
|
[8]
|
Muchow M, Maincent P, Müller RH. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement[J]. Drug Devel Industr Pharm, 2011, 37(1): 8-14. |
|
[9]
|
Chakraborty S, Shukla D, Mishra B, et al. Lipid—an emerging platform for oral delivery of drugs with poor bioavailability[J]. Eur J Pharm Biopharm,2009,73:1-15. |
|
[10]
|
Sahu MK, Soni GC, Prajapati SK. Formulation and characterization of topical nanostructured lipid carrier gel of flurbiprofen and its comparisonwith micellar gel prepation[J]. World J Pharm Pharm Sci,2012,1(3):1235-1247. |
|
[11]
|
Luo YF,Chen DW,Ren LX,et al. Solid lipid nanopartcles for enhancing vinpocetines oral bioavailability[J]. Contr Rel, 2006, 114: 53- 59. |
|
[12]
|
Thomson AB, Schoeller C, Keelan M, et al. Lipid absorption: passing through theunstirred layers, brush-border membrane, and beyond[J]. Can J Physiol Pharmacol, 1993, 71 (8):531-555. |
|
[13]
|
孙明辉.西罗莫司自微乳化释药系统的研究[D].湖北:华中科技大学,2012. |
|
[14]
|
Müller RH,Runge S,Ravelli V,et al.Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals[J].Int J Pharm,2006,317(1):82-89. |
|
[15]
|
Elgart A, Cherniakov I, Aldouby Y, et al.Improved oral bioavailability of BCS class 2 compounds by self nano-emulsifying drug delivery systems (SNEDDS):the underlying mechanisms for amiodarone and talinolol[J].Pharm Res,2013(5):212-215. |
|
[16]
|
Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability[J]. Int J Pharm,2010,394(1):179-185. |
|
[17]
|
胥 娜,钟文英,朱丹妮.固体脂质纳米粒在提高难溶性药物生物利用度中的应用[J].中华中医药学刊,2007,25(8):1605-1607. |
|
[18]
|
Mu HL, Hφy CE. The digestion of dietary triacylglycerols[J]. Prog Lipid Res, 2004, 43(2):105-133. |
|
[19]
|
Ravi D, Hywel DW, Dallas B, et al. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products[J]. Int J Pharm,2013,441(1):323-333. |
|
[20]
|
Hans B, Jenneke P,Ruud J, et al. Characterization of translocation of silver nanoparticles and effects on whole-genome gene expression using an in vitro intestinal epithelium coculture model[J]. ACS Nano, 2011, 5 (5): 4091-4103. |
|
[21]
|
Takeuchi H, Yamamoto H, Kawashima Y, et al. Mucoadhesive nanoparticulate systems for peptide drug delivery[J]. Adv Drug Deliv Rev,2001,47(1):39. |
点击查看大图
下载:
